Recent Quotes (30 days)

You have no recent quotes
chg | %

Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 214   

Articles published

VRX 12.05 -0.08 (-0.66%)
price chart
Valeant Pharmaceuticals Intl Inc. Is Down 15%: Is it a Buy?
When you're dealing with a beaten-down and debt-ridden company like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), things are going to get volatile.
The Lesson of Enterprise Value for Valeant Pharmaceuticals Intl Inc
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Lowered to Hold at Vetr Inc.  Dispatch Tribunal
Valeant Announces Pricing Of Private Offering Of Senior Secured Notes
LAVAL, Quebec, Oct. 2, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has priced its previously announced offering of $1,000,000,000 aggregate principal amount of ...
Valeant Pharmaceuticals Intl Inc.: Value Trap or Opportunity?
Among the dizzying array of investment opportunities on the market, Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) continues to attract significant attention from both buying and selling pundits.
Valeant Pharmaceuticals Provides Update On Canadian Regulatory Filing About ...  Canada NewsWire (press release)
Valeant to Participate at the Deutsche Bank 25th Annual Leveraged Finance ...  PR Newswire (press release)
Is it Time to Say Goodbye to Valeant Pharmaceuticals Intl Inc.?
Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) were on fire earlier this year, having risen an amazing 92% in the four months between April and July.
Valeant Pharmaceuticals International Breaks Below 200-Day Moving Average ...  Nasdaq
Cantor Pounds the Table on Valeant Pharmaceuticals Intl Inc (VRX)  Smarter Analyst
Valeant: Awash With Cash
All 15 pharma and biotech firms could use 100% debt financing to pay for Valeant, as the maximum leverage that would result would be 4.2x net debt/EBITDA for AstraZeneca.
Is a $5 Billion Debt Reduction for Valeant Pharmaceuticals Intl Inc. Enough?
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) pledged to reduce its debt by $5 billion last year. In September, Valeant announced that it was selling its iNova business for $930 million, with $920 million of that going towards reducing its debt.
How to Approach Valeant Pharmaceuticals Intl Inc (VRX) Stock With Reason
iNova Multiples Are Unimpressive - Uncertainty Persists For Valeant  Seeking Alpha
Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early ...
LAVAL, Quebec, Oct. 16, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant") announced today the results to date of the pending cash tender offers (the "Tender Offers") by Valeant and Valeant Pharmaceuticals ...
(VRX) Shares Trading down at $12.92 Valeant And One Of Its Subsidiaries…  HugoPress
Is Shopify Inc. the Next Valeant Pharmaceuticals Intl Inc.?
Shopify Inc. (TSX:SHOP)(NYSE:SHOP) shares plunged as low as ~13% on Wednesday following a report released by the infamous short-seller Andrew Left of Citron Research, who triggered the downfall of Valeant Pharmaceuticals Intl Inc.
Left Is Kind of Right on Shopify Inc (US) (SHOP) Stock
Valeant Pharmaceuticals Completes Sale Of iNova Pharmaceuticals To Pacific ...
LAVAL, Quebec, Sept. 29, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced that it has completed the sale of the iNova Pharmaceuticals ("iNova") business to a company ...
Valeant Pharmaceuticals International, Inc. (VRX) has a value of $13.76 per ...  Stocks Gallery
Valeant Pharmaceuticals International, Inc. (VRX) Recent Ownership Changes  Post Analyst
Valeant Pharmaceuticals International is Now Oversold (VRX)
In trading on Thursday, shares of Valeant Pharmaceuticals International Inc (Symbol: VRX) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $11.89 per share.